Drug discovery with Andrew Petros from AbbVie: Use of biophysical methods to drive discovery of the apoptosis promoter navitoclax

Description: Join Andrew Petros, Senior Principal Research Scientist at AbbVie, for a seminar about drug discovery. Dr. Petros is the co-discoverer of the drug Venetoclax, which received FDA approval this June and has a 2020 sales forecast of $1.48 billion. Come with questions about Dr. Petros’ career in drug discovery and learn more about his approach here. Lunch will be provided, please RSVP. Questions? Contact Liz Loughran at or 574-631-2080.

Originally published at